期刊文献+

血浆N-末端脑钠肽前体质量浓度对急性呼吸困难的诊断意义 被引量:5

Value of plasma NT-proBNP levels in diagnosing and differentiating in acute dyspnea patients
暂未订购
导出
摘要 目的:探讨血浆N-末端脑钠肽前体(NT-proBNP)质量浓度变化在急性心源性呼吸困难诊断和鉴别诊断中的临床意义。方法:选取以呼吸困难为主诉来我院急诊的患者110例,分为心源性呼吸困难组64例和非心源性呼吸困难组46例,采用酶联免疫吸附法(ELISA)检测血浆NT-proBNP质量浓度。结果:心源性呼吸困难组与非心源性呼吸困难组血浆NT-proBNP质量浓度分别为(3 641.48±2 931.53)ng.L-1和(565.83±301.53)ng.L-1,两组间比较差异有统计学意义(P<0.01)。心源性呼吸困难组中不同NYHA心功能分级的患者血浆NT-proBNP质量浓度比较差异有统计学意义(P<0.01),心功能分级越差,NT-proBNP质量浓度越高;以NT-proBNP质量浓度600 ng.L-1作为临界值,血浆NT-proBNP质量浓度对心源性呼吸困难诊断的敏感性很高(93.75%),但特异性略差(69.56%)。结论:快速检测血浆NT-proBNP用来诊断心力衰竭特别是左心衰的方法可靠、稳定、敏感、快捷,可作为鉴别急性呼吸困难病因的一个重要检查方法。 Objective:To investigate the clinical value of the plasma NT-proBNP levels in patients with acute cardiac dyspnea or noncardiac dyspnea.Methods:110 patients with acute dyspnea were divided into two groups:cardiac dyspnea group(64 cases) and noncardiac dyspnea group(32 cases).The plasma NT-proBNP level was measured by enzyme-linked immunosorbent assay(ELISA).Results:The plasma NT-proBNP level of the cases with cardiac dyspnea and non cardiacdyspnea was(3641.48±2931.53)ng·L-1 and(565.83±301.53)ng·L-1 respectively with a significant difference(P〈0.01).The plasma NT-proBNP level in the cases with different classes of the NYHA heart function was also significantly different(P〈0.01),and the worse heart function,the higher plasma NT-proBNP level was.If 600 ng·L-1 was taken as a critical value,the plasma NT-proBNP level was excellently sensitive for diagnosing cardiac dyspnea(93.75%),but the specificity was not very good(69.56%).Conclusion:The plasma NT-proBNP level is highly sensitive for diagnosing cardiac dyspnea and differentiating with noncardiac dyspnea,which works in a convenient rapid way in clinic.
出处 《现代医学》 2011年第2期197-199,共3页 Modern Medical Journal
关键词 血浆N-末端脑钠肽前体 心力衰竭 呼吸困难 NT-proBNP heart failure dyspnea
  • 相关文献

参考文献7

  • 1SUDOH T,KANGAWA K,MINAMINE N,et al.A new natriuretic peptide in porcine brain[J].Nature,1988,33(2):78-81.
  • 2胡大一 杨振华.B型钠尿肽的临床应用和最新进展.中华心血管病杂志,2004,32(1):51-52.
  • 3NIELSEN O W,KIRK V,BAY M,et al.Value of N-terminal probrain natriuretic peptide in the elderly∶data from the prospective Copenhagen hospital heart failure study[J].Eur Heart Fail,2000,10(5):275-279.
  • 4DOWNIE P F,TALWAR S,SQUIRE I B,et al.Assessment of the stability of N-terminal proBNP in vitro∶implications for assessment of left ventricular dysfunction[J].Clin Sci,2002,97(10):255-258.
  • 5YOSHIHIKO S,TERUYO Y.Application of NT-proBNP and BNP measurements in care:a more discerning marker for the detection and evaluation of heart failure[J].Eur Heart Fail,2003,12(6):295-300.
  • 6史晓敏,林箐,徐国宾,宋以信,夏铁安.血清N末端B型钠尿肽原在心功能评价及慢性充血性心力衰竭诊断中的初步应用[J].中华检验医学杂志,2005,28(1):37-41. 被引量:78
  • 7MAISEL A S,KRISHNASWAMY P,NOWAK R M,et al.Rapid measurement of N-terminal protein brain natriureic peptide in the emergency diagnosis of heart failure[J].Card Fail,2002,6(5):123-126.

二级参考文献10

  • 1史晓敏,宋以信,徐国宾,夏铁安.人血清N端脑钠肽水平参考值范围及其测定稳定性的初步调查[J].中国实验诊断学,2004,8(5):451-455. 被引量:18
  • 2Hunt PJ, Richards AM, Nicholls MG, et al. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol, 1997, 47:287 -296.
  • 3Yeo KT , Wu AH , Apple FS, et al. Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta, 2003, 338:107-115.
  • 4Cowie MR, Struthers AD, Wood DA, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet, 1997, 350:1349-1353.
  • 5McDonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet, 1998, 351:9-13.
  • 6Pfister R, Scholz M, Wielckens K, et al. Use of NT-proBNP in routing testing and comparison to BNP. Eur J Heart Fail, 2004, 6:289 -293.
  • 7Seino Y, Ogawa A, Yamashita T, et al. Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure. Eur J Heart Fail, 2004, 6:295-300.
  • 8McCullough PA, Sandberg KR. B-type natriuretic peptide and renal disease. Heart Fail Rev, 2003, 8:355 -358.
  • 9Richards AM , Nicholls MG , Yandle TG , et al. Plasma N-terminal pro-brain natriureitc peptide and adrenomedullin: new neurohormonal predictors of left ventriculation function and prognosis after myocardial infarction. Circulation, 1998, 97:1921-1929.
  • 10张国华,胡韵,史晓敏,徐国宾,夏铁安.B型钠尿肽的生物学特性及其在心脏病学中的临床应用进展[J].中华检验医学杂志,2004,27(4):262-265. 被引量:76

共引文献78

同被引文献38

  • 1谢洪智,朱文玲.重组人脑利钠肽和硝酸甘油治疗急性失代偿性心力衰竭疗效和安全性的随机、开放、平行对照的多中心临床研究[J].中华心血管病杂志,2006,34(3):222-226. 被引量:228
  • 2付尧,白小涓,杨光,贾大林,齐国先.重组人脑利钠肽治疗慢性心力衰竭对醛固酮及内皮素-1的影响[J].中国循环杂志,2007,22(1):35-37. 被引量:9
  • 3陈桂申,段永强,付曼妮.肺心病患者急性期红细胞参数和血液流变学指标变化[J].微循环学杂志,2007,17(3):63-63. 被引量:2
  • 4BURNETF J C. Natriuretic peptides and remodeling in heart failure [ J ]. Heart Fail Clin, 2005,1 (12) : 129-139.
  • 5KAWAKAMIN R, SA1TO Y, KISHIMOTO I, et al. Over expression of brain natriuretic peptide facilitates neutrophil infiltration and cardiac matrix metalloproteinase 29 expression after acute myocardial infraction [ J ]. Circulation, 2004,110 ( 23 ) : 33062-33121.
  • 6STRAIN W D. The use of recombinant human B-type natriuretic peptide(nesiritide) in the management of acute decompensated heart failure [ J ]. Int J Clin Pract, 2004,58 ( 11 ) : 1081-1087.
  • 7COLUCCI W S, ELKAYAM E, HORTON D P, et al. Intravenous nesiritide, a natriuretic peptide, in the treatment ofdecompensated heart failure [ J ]. N Engl Med, 2000,343 (24) :2462-2531.
  • 8叶任高,陆再英.内科学,北京[M].人民卫生出版社.2006.116-117.
  • 9徐盈,陈国兵,余天燕,等.低分子肝素治疗肺心病血栓前状态的近期疗效及血流动力学变化[J].中国医师进修杂志,2012,35(z1):184-186.
  • 10XUE M, YIN H,ZHANG L , et al. Dynasimic expression of the main related indicators of thrombosis, inflammatory reaction and tissue damage in a rat model of myocardial infarction [ J ]. Mol Med Rep,2011,4(4) :693-696.

引证文献5

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部